At what age do kids need to repeat pneumococcal (PCV13) vaccination?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 11, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Pneumococcal Vaccination Booster Timing in Children

For healthy children who complete the primary PCV13 series (doses at 2,4, and 6 months), the booster dose must be given at 12-15 months of age, at least 8 weeks after the third dose. 1

Standard Vaccination Schedule by Age

Infants Starting at 2-6 Months

  • Primary series: 3 doses at 2,4, and 6 months with minimum 4-week intervals between doses 1
  • Booster dose: Single dose at 12-15 months, at least 8 weeks after the third primary dose 1, 2
  • This completes the standard 4-dose series for healthy children 1

Catch-Up Schedules for Late Starters

Children 7-11 months at first dose:

  • Give 2 primary doses with at least 4-week intervals 1
  • Booster dose at 12-15 months, at least 8 weeks after the second dose 1, 2

Children 12-23 months at first dose:

  • Give 2 doses total, spaced at least 8 weeks apart 1
  • No separate booster is needed—the second dose serves as the final dose 1

Healthy children 24-59 months:

  • Give only 1 dose if previously unvaccinated or incompletely vaccinated 1
  • No booster needed at this age for healthy children 1, 2

Special Populations Requiring Additional Doses

Children 24-71 months with high-risk conditions (immunocompromising conditions, functional/anatomic asplenia, sickle cell disease, HIV infection, cochlear implants, or CSF leaks):

  • Give 2 doses spaced 8 weeks apart if they received fewer than 3 doses before age 24 months 1, 2
  • If they completed a 4-dose series, give 1 supplemental dose at least 8 weeks after the most recent dose 1, 2

Children 6-18 years with high-risk conditions:

  • Give a single dose of PCV13 if not previously received, regardless of prior PCV7 or PPSV23 vaccination 1, 2

Critical Timing Rules

  • Minimum interval for children ≥12 months: 8 weeks between any PCV13 doses 1, 2
  • Minimum interval for infants <12 months: 4 weeks between primary series doses 1, 2
  • Earliest first dose: Can be given as early as 6 weeks of age 1

Long-Term Protection

Healthy children do not need repeat vaccination after completing the age-appropriate series. 3 The standard 4-dose PCV13 series provides durable protection throughout childhood without additional booster doses beyond the toddler dose at 12-15 months. 3 No routine pneumococcal conjugate vaccine doses are recommended for healthy children after age 5 years. 3

Common Pitfalls to Avoid

  • Missing the supplemental dose: Children aged 14-59 months who completed PCV7 series need one supplemental PCV13 dose at least 8 weeks after their last PCV7 dose 1, 4
  • Inadequate intervals: Always ensure at least 8 weeks between doses for children ≥12 months; giving doses too close together reduces immunogenicity 1
  • Overlooking high-risk children: Children with underlying medical conditions require additional doses through age 71 months, not just through age 59 months like healthy children 1, 2

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

PCV13 Vaccination Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Duration of Pneumococcal Conjugate Vaccine Protection in Children

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.